1. Activist Investor Blasts Alexion's $1.4B Portola Buy in Scathing Open Letter

    Activist Investor Blasts Alexion's $1.4B Portola Buy in Scathing Open Letter

    Nearly four years removed from a disastrous sales fraud probe and an overhaul of its senior leadership, Alexion has launched a campaign to bolster its rare disease pipeline through pricey acquisitions. But one activist investor thinks Alexion's strategy is ill-conceived––and the old foe is airing its grievances in public...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Alexion maintains an active dialogue with shareholders and welcomes input and feedback as we execute on our transformation strategy.
    2. The way we look at value here is long-term value.
  3. Topics Mentioned